Despite a growing literature on the life course of attention-deficit/hyperactivity disorder (ADHD), a comprehensive understanding of one of the most feared outcomes, substance use disorders (SUD), is lacking. Moreover, many adolescents and adults with SUD may have undiagnosed and untreated ADHD. Dr. Wilens will discuss the relationship of ADHD and SUD across the lifespan. Data on prevention of SUD in ADHD individuals growing up will be presented. Treatment strategies including psychotherapy and/or medication treatment in individuals with comorbid ADHD and SUD will be presented, along with recent data about stimulant misuse and diversion.
Women of reproductive age are often treated for psychiatric disorders and are on maintenance treatment. Approximately 50% of pregnancies in the United States are unplanned. Dr. Freeman will discuss the considerations for stopping or continuing different pharmacologic treatments during pregnancy for common psychiatric disorders, including mood disorders, anxiety disorders, attention-deficit/hyperactivity disorder, and psychotic disorders.
Best practices in attention-deficit/hyperactivity disorder (ADHD) management require skilled use of alternative treatments in conjunction with evidence-based medication use. This session will review the practical use of cognitive-behavioral therapy, mindfulness/meditation, and exercise therapies. Dr. Mason will also discuss primary use of non-stimulant medication with stimulant augmentation in partial responders, which can be an effective and tolerable alternative to stimulant monotherapy.